We previously identified a 65-kDa protein (p65) that was phosphorylated in activated macrophages. It has turned out to be a murine homologue of human L-plastin, which was identified as a novel protein in human cancer cells. p65/L-plastin is characterized by a series of Ca2+-, calmodulin-, and actin-binding domains, and is thought to play a crucial role in leukocytes and cancer cells. We have expressed a recombinant (r) p65/L-plastin in Escherichia coli that binds to β-actin and prepared high-titer antibodies using large amounts of the protein as immunogen. Anti-rp65/L-plastin antibodies recognize native p65/L-plastin as well as rp65/L-plastin and have enabled us to detect the fine structures of intracellular p65/L-plastin, and it was found that its localization was extensively changed by stimulation with bacterial components. We further developed an enzyme-linked immunosorbent assay system and a flow cytometry method using these reagents, which made it possible to measure antibodies, including autoantibodies, against p65/L-plastin and to evaluate the maturation-dependent expression of the protein in leukocytes. © 2003 by Japan Society for Bioscience, Biotechnology, and Agrochemistry.
CITATION STYLE
Shinomiya, H., Nagai, K., Hirata, H., Kobayashi, N., Hasegawa, H., Liu, F., … Asano, Y. (2003). Preparation and characterization of recombinant murine p65/l-plastin expressed in escherichia coli and high-titer antibodies against the protein. Bioscience, Biotechnology and Biochemistry, 67(6), 1368–1375. https://doi.org/10.1271/bbb.67.1368
Mendeley helps you to discover research relevant for your work.